Evidence map›Paper›PMID 40862028›Full record

ArticleCureus2025

Burden and Outcomes of Cardiovascular Diseases in the ICU of a Nigerian Tertiary Hospital.

Boma Oyan, Marcel F Jumbo, Sarah Abere

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Boma OyanInternal Medicine, Rivers State University Teaching Hospital, Port-Harcourt, NGA.
Marcel F JumboInternal Medicine, Rivers State University Teaching Hospital, Port-Harcourt, NGA.
Sarah AbereInternal Medicine, Rivers State University Teaching Hospital, Port-Harcourt, NGA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe rising prevalence of cardiovascular diseases in Nigeria makes it imperative to develop specialised cardiac intensive care units (CICU) with uniquely trained staff for the management of critically ill cardiac cases that are currently being managed in the general ICU. This study aimed to describe the clinical characteristics and outcomes of patients with cardiac disease admitted into the ICU of the University of Port Harcourt Teaching Hospital.

methodsThis was a retrospective cross-sectional hospital-based study. The records of medical patients admitted into the ICU from January 2019 to December 2023 were studied. Patients' biodata, clinical information, and outcomes were extracted. Data was analysed using SPSS version 25 (IBM Corp., Armonk, NY).

resultsCardiac diseases accounted for 91 (28.0%) of the 325 medical patients admitted into the ICU with a mean age of 55.9±17.4years, and 46 (50.5%) were men. Hypertensive emergencies were the commonest cardiac indication for admission in 29 (31.9%) persons, followed by acute decompensated heart failure (ADHF) and pulmonary embolism in 24(26.4%) and 22 (24.2%) persons, respectively. Others included cardiogenic shock in nine (9.9%), unstable arrhythmias in five (5.5%), and acute myocardial infarction in two (2.2%) patients. A total of 50 (54.9%) persons admitted for cardiovascular disease died, with a significant relationship between increasing age (p=0.046), use of ionotropic/vasoactive medication (p=0.002), and use of mechanical ventilation (p=0.048) with mortality.

conclusionHypertensive emergencies and ADHF emerged as significant contributors to cardiac morbidity and mortality in the ICU. This data may be useful to guide cardiac critical care redesign to improve patient outcomes.

Indexed as

cardiovascularcritical careicuintensive cardiac care unitmortalitynigeria

Identifiers

PMID40862028
PMCPMC12375366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.